Nasus Pharma Ltd.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2023 | — | $-3.8M | $193.0K |
| FY2024 | — | $-3.2M | $284.0K |
| FY2025 | — | $2.8M | $1.2M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2023 | — | $-3.8M | $193.0K |
| FY2024 | — | $-3.2M | $284.0K |
| FY2025 | — | $2.8M | $1.2M |